Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,990 | 71 | 99.1% |
| Education | $71.49 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,743 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,333 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,201 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,111 | 10 | $0 (2023) |
| ITI, Inc. | $962.58 | 9 | $0 (2023) |
| Axsome Therapeutics, Inc. | $450.78 | 4 | $0 (2024) |
| Alkermes, Inc. | $342.79 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $212.37 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $176.00 | 2 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $125.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,278 | 11 | ABBVIE INC. ($342.50) |
| 2023 | $2,194 | 20 | Teva Pharmaceuticals USA, Inc. ($510.18) |
| 2022 | $2,343 | 21 | Janssen Pharmaceuticals, Inc ($558.42) |
| 2021 | $1,793 | 16 | AbbVie Inc. ($423.11) |
| 2020 | $242.87 | 2 | Teva Pharmaceuticals USA, Inc. ($125.00) |
| 2018 | $86.48 | 1 | Sunovion Pharmaceuticals Inc. ($86.48) |
| 2017 | $125.00 | 1 | Otsuka America Pharmaceutical, Inc. ($125.00) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $90.79 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $83.79 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $118.92 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 04/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $118.54 | General |
| Category: CNS | ||||||
| 03/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: Neuroscience | ||||||
| 03/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $117.07 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Neuroscience | ||||||
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $123.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Neurology | ||||||
| 10/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $60.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $124.96 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $110.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: PSYCHIATRY | ||||||
| 06/02/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $71.49 | General |
| 06/01/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $102.50 | General |
| Category: Central Nervous System | ||||||
| 05/18/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $124.96 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/26/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $111.11 | General |
| Category: Neuropsychiatry | ||||||
| 04/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $99.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Naeem Aftab, MD
Dr. Naeem Aftab, MD is a Psychiatry healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679668719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Naeem Aftab, MD has received a total of $8,062 in payments from pharmaceutical and medical device companies, with $1,278 received in 2024. These payments were reported across 72 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($7,990).
Practice Information
- Specialty Psychiatry
- Location Newburgh, NY
- Active Since 10/04/2006
- Last Updated 05/25/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679668719
Products in Payments
- VRAYLAR (Drug) $1,743
- INVEGA SUSTENNA (Drug) $1,128
- CAPLYTA (Drug) $1,053
- ABILIFY MAINTENA (Drug) $851.27
- AUSTEDO (Drug) $812.16
- Auvelity (Drug) $450.78
- REXULTI (Drug) $225.00
- ARISTADA (Drug) $224.25
- INGREZZA (Drug) $212.37
- SPRAVATO (Drug) $204.48
- NURTEC ODT (Drug) $125.00
- ABILIFY ASIMTUFII (Drug) $124.99
- UZEDY (Drug) $124.96
- LYBALVI (Drug) $118.54
- Nuedexta (Drug) $115.04
- Austedo XR (Drug) $102.50
- QUVIVIQ (Drug) $100.00
- Dayvigo (Drug) $98.35
- LATUDA (Drug) $86.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newburgh
Dr. Louis Cady, Md, MD
Psychiatry — Payments: $174,319
Dr. Todd Rochman, M.d, M.D
Psychiatry — Payments: $33,511
Mr. Abdul Qayyum, M.d, M.D
Psychiatry — Payments: $17,535
Mr. Salil Kathpalia, Md, MD
Psychiatry — Payments: $5,102
Dr. Lavinia Park, M.d, M.D
Psychiatry — Payments: $2,045
Mr. Martin Wolfson, Md, MD
Psychiatry — Payments: $1,498